Thus the usefulness of this drug in treating obesity deserves further exploration, to define the AgRP dependent and independent mechanisms by which TTP2515 exerts its effects on energy balance. The gene discussed is AGRP; the disease is obesity due to melanocortin 4 receptor deficiency.